Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Astra's shipments for 9 months increased by 98%

10/14/24 ASTR

Non-residents bought back ₽2.54 billion worth of Russian assets

10/14/24 MOEX

Novabev Group distillery temporarily lost its license

10/14/24 BELU

Artgen Biotech invests in RBT platform

10/11/24 RBTY

Artgen Biotech invests in vaccine creation platform

10/11/24 ABIO

Moscow Exchange has withdrawn from KASE's shareholder structure

10/11/24 MOEX

Positive Technologies will enter the autopentest market

10/11/24 POSI

Aeroflot's passenger traffic in September increased by 16.4%

10/11/24 AFLT

VK fires inefficient employees

10/11/24 VKCO

Magnit opened the first franchise store

10/11/24 MGNT